"i.v.STATION's $300,000 price, combined with its plug-and-play installation, flexibility of IV Bags/Vials/Syringes, ISO-5 controlled environment, and unprecedented robotic throughput, has already revolutionized Non-Hazardous Sterile Compounding in North America. Multiple hospital studies have proven an i.v.STATION's 3-to-1 cost advantage over Pre-Mix/Frozen solutions by Baxter, B. Braun, and Hospira, resulting on an average 8-month payback period to American hospitals utilizing between 1,200 and 1,400 median Minibag Plus, Duplex, or ADD-Vantage IV doses per month. As many North American hospitals have lately been forced towards increased IV Outsourcing as a result of recent IV drug shortages, i.v.STATION arrives at the right place and at the right time, offering a much more cost effective solution to the widespread scarcity problem in selected antibiotics, pain therapy, and other IV drug classes, while providing Health-System Pharmacies with much more control over Batch IV production and reduced IV waste," stated Gaspar DeViedma, Health Robotics' Executive Vice President.
i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, cost effective, and ready-to-administer intravenous patient doses. i.v.STATION offers unprecedented reduction of IV medication errors, USP 797 compliance, compatibility with 75+ different Syringe and IV Bags brands/sizes, reduction of IV waste, and significant labor savings: all within a scalable, cost-effective, distributed, and fail-safe architecture.
"i.v.STATION has also consistently revealed a 6-to-1 cost advantage over
|SOURCE Health Robotics|
Copyright©2010 PR Newswire.
All rights reserved